Skip to main content

Lost Productivity in Four European Countries among Patients with Rheumatic Disorders

Are Absenteeism and Presenteeism Transferable?

PharmacoEconomics volume 30, pages 795–807 (2012)Cite this article

Abstract

Background: When national pharmacoeconomic guidelines are compared, different recommendations are identified on how to identify, measure and value lost productivity, leading to difficulties when comparing lost productivity estimates across countries. From a transferability point of view, the question arises of whether differences between countries regarding lost productivity are the result of using different calculation methods (methodological differences) or of other between-country differences. When lost productivity data differ significantly across countries, the transferability of lost productivity data across countries is hindered.

Objective: The objective of this study was to investigate whether country of residence has a significant influence on the quantity of lost productivity among patients with rheumatic disorders. Confounding factors that might differ between countries were corrected for, while the methodology used to identify and measure lost productivity was kept the same.

Methods: This question was investigated by means of an online questionnaire filled out by 200 respondents with a rheumatic disorder per country in four European countries, namely the Netherlands, the UK, Germany and France. In addition to those regarding lost productivity, the questionnaire contained questions about patient characteristics, disability insurance, disease characteristics, quality of life and job characteristics as these variables are expected to influence lost productivity in terms of absenteeism and presenteeism. The data were analysed by regression analyses, in which different components — being absent in last 3 months, number of days absent and presenteeism — of lost productivity were the main outcome measures and other variables, such as gender, impact of disease, shift work, job control, partial disability and overall general health, were corrected for.

Results: The results showed that country sometimes has a significant influence on lost productivity and that other variables such as, for example, age, disease severity, number of contract hours, decision latitude, experienced health (as reported on the visual analogue scale) and partial disability, also influence lost productivity. A significant influence of country of residence was found on the variables ‘being absent in the last three months’, ‘number of days absent’ and ‘quality of work on the last working day’. However, country did not influence ‘quantity of work on the last working day’ and ‘overall presenteeism on the last working day’.

Conclusion: It can be concluded that country has a significant influence on lost productivity among patients with rheumatic disorders, when corrected for other variables that have an influence on absenteeism and presenteeism. Transferring lost productivity data across countries without adaptation is hindered by the significant differences between countries in this patient group. As a result, transferring lost productivity data, being either monetary values or volumes of productivity losses, between countries can give wrong estimations of the cost effectiveness of treatments.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

49,54 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Table I
Table II
Table III
Table IV

References

  1. Tarn TYH, Dix Smith M. Pharmacoeconomic guidelines around the world. ISPOR Connections 2004; 10(4): 5–15

    Google Scholar 

  2. Drummond MF, Bloom BS, Carrin G, et al. Issues in the cross-national assessment of health technology. Int J Tech-nol Assess Health Care 1992; 8(4): 671–82

    CAS  Google Scholar 

  3. Greiner W, Schöffski O, Graf von der Schulenberg JM. The transferability of international economic health-economic results to national study questions. Eur J Health Econ 2000; 1: 94–102

    Article  Google Scholar 

  4. Mulligan J-A, Fox-Rushby J. Chapter 18: transferring cost-effectiveness data across space and time. In: Fox-Rushby J, Cairns J, editors. Economic evaluation. Maidenhead: Open University Press, 2005

    Google Scholar 

  5. Welte R, Feenstra F, Jager H, et al. R. A decision chart for assessing and improving the transferability of economic evaluation results between countries. Pharmacoeconomics 2004; 22(13): 857–76

    PubMed  Article  Google Scholar 

  6. Drummond M, Barbieri M, Cook JR, et al. Transferability of economic evaluations across jurisdictions: ISPOR good research practices task force report. Value Health 2009; 12(4): 409–18

    PubMed  Article  Google Scholar 

  7. Goeree R, Burke N, O’Reilly D, et al. Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another. Curr Med Res Opin 2007; 23(4): 671–82

    PubMed  Article  Google Scholar 

  8. Franke LC, Ament AJHA, Van de Laar MAFJ, et al. Cost-of-illness of rheumatoid arthritis and ankylosing spondy-litis. Clin Exp Rheumatol 2009; 27 Suppl. 55: S1 18–23

    CAS  Google Scholar 

  9. Knies S, Severens JL, Ament AJHA, et al. The transferability of valuing lost productivity across jurisdictions: differences between national pharmacoeconomic guidelines. Value Health 2010; 13(5): 519–27

    PubMed  Article  Google Scholar 

  10. Van den Heuvel SG, Geuskens GA, Hooftman WE, et al. Productivity loss at work; health-related and work-related factors. J Occup Rehabil 2010; 20(3): 331–9

    PubMed  Article  Google Scholar 

  11. Duijts SFA, Kant Y, Swaen GMH, et al. A meta-analysis of observational studies identifies predictors of sickness absence. J Clin Epidemiol 2007; 60: 1105–15

    PubMed  Article  Google Scholar 

  12. Laaksonen M, Martikainen P, Rahkonen O, et al. Explanations for gender differences in sickness absence: evidence from middle-aged municipal employees from Finland. Occup Environ Med 2008; 65: 325–30

    PubMed  Article  CAS  Google Scholar 

  13. Kobelt G, Woroneff A-S, Richard B, et al. Disease status and quality of life with rheumatoid arthritis in France: the ECO-PR study. Joint Bone Spine 2008; 75: 408–15

    PubMed  Article  Google Scholar 

  14. Brouwer WBF, Meerding WJ, Lamers LM, et al. The relationship between productivity and health-related QOL. Pharmacoeconomics 2005; 23(3): 209–18

    PubMed  Article  Google Scholar 

  15. Boonen A, Van der Heijde D, Landewe R, et al. Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries. Ann Rheum Dis 2002; 61: 429–37

    PubMed  Article  CAS  Google Scholar 

  16. Severens JL, Laheij RJF, Jansen JBM, et al. Estimating the cost of lost productivity in dyspepsia. Aliment Pharmacol Ther 1998; 12: 919–23

    PubMed  Article  CAS  Google Scholar 

  17. Gimeno D, Benavides FG, Benach J, et al. Distribution of sickness absence in the European Union countries. Occup Environ Med 2004; 31: 867–9

    Article  Google Scholar 

  18. Boonen A, Severens JL. Worker participation in rheumatic disease: the socioeconomic perspective. Chesterfield: Arthritis Research Campaign, 2009

    Google Scholar 

  19. De Wolf P, Brouwer WBF, Rutten FFH. Regulating the Dutch pharmaceutical market: improving efficiency or controlling costs? Int J Health Plann Manage 2005; 20: 351–74

    PubMed  Article  Google Scholar 

  20. Chevalier J, De Pouvourville G. Valuing EQ-5D using time trade-off in France [abstract]. Value Health 2009; 12(7): A224

    Article  Google Scholar 

  21. Szende A, Oppe M, Devlin N. EQ-5D value sets: inventory, comparative review and user guide. Dordrecht: Springer, 2007

    Book  Google Scholar 

  22. Koopmanschap MA. PRODISQ: a modular questionnaire on productivity and disease for economic evaluation studies. Expert Rev Pharmacoeconomics Outcomes Res 2005; 5(1): 23–8

    Article  Google Scholar 

  23. Koopmanschap MA, Meerding WJ, Evers S, et al. PRO-ductivity and DISease Questionnaire (PRODISQ); Een modulaire vragenlijst over de relatie tussen ziekte en productiviteitskosten, toepasbaar bij economische evaluaties van gezondheidszorgprogramma’s voor pati ënten en werk-nemers. Rotterdam/Maastricht: Instituut voor Medical Technology Assessment, Erasmus Universiteit Rotterdam/Instituut Maatschappelijke Gezondheidszorg, Erasmus Medisch Centrum/Beleid Economie en Organisatie van de Zorg, Universiteit Maastricht, 2004

  24. Karasek R, Baker D, Marxer F, et al. Job decision latitude, job demands and cardiovascular disease: a prospective study of Swedish men. Am J Public Health 1981; 71: 694–705

    PubMed  Article  CAS  Google Scholar 

  25. Riemsma RP, Taal E, Rasker JJ, et al. Evaluation of a Dutch version of the AIMS2 for patients with rheumatoid arthritis. Br J Rheumatol 1996; 35: 755–60

    PubMed  Article  CAS  Google Scholar 

  26. Eurostat Unit F/5. European Health Interview Survey (EHIS) questionnaire. Luxembourg: European Commission Eurostat, 2006

    Google Scholar 

  27. Kirk RE. Experimental design: procedures for the behavioral sciences. Belmont (CA): Wadsworth, 1982

    Google Scholar 

Download references

Acknowledgements

The authors declare no funding support was received for this paper and no author has any potential conflict of interest to declare.

SK is responsible for the questionnaire, data collection and drafted the manuscript. MC is a statistician who advised and helped with the statistical analyses in this manuscript. AB is a rheumatologist and advised about disease specific measures when constructing the questionnaire and the interpretation of the results. SE and AA supervised the drafting of the questionnaire and the writing of the manuscript. JS helped with the construction of the questionnaire and the interpretation of the results of the analyses. All authors read, edited and approved the final manuscript.

Author information

Affiliations

  1. Department of Health Services Research, School for Public Health and Primary Care (CAPHRI), Faculty of Health, Medicine and Life Sciences, Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands

    Saskia Knies, Silvia M. A. A. Evers, Andre J. H. A. Ament & Johan L. Severens

  2. Department of Methodology and Statistics, School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, The Netherlands

    Math J. J. M. Candel

  3. Department of Internal Medicine, Division of Rheumatology, School for Public Health and Primary Care (CAPHRI), Maastricht University Medical Center, Maastricht, The Netherlands

    Annelies Boonen

  4. Institute of Health, Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands

    Johan L. Severens

Authors
  1. Saskia Knies
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Math J. J. M. Candel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Annelies Boonen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Silvia M. A. A. Evers
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Andre J. H. A. Ament
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Johan L. Severens
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Saskia Knies.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Knies, S., Candel, M.J.J.M., Boonen, A. et al. Lost Productivity in Four European Countries among Patients with Rheumatic Disorders. PharmacoEconomics 30, 795–807 (2012). https://doi.org/10.2165/11591520-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11591520-000000000-00000

Keywords

  • Social Security System
  • Decision Latitude
  • Disability Insurance
  • Rheumatic Disorder
  • Lost Productivity